- Report
- January 2022
- 230 Pages
Global
From €4096EUR$4,600USD£3,550GBP
- Report
- December 2021
Global
€4230EUR$4,750USD£3,666GBP
- Database
- December 2021
United States
From €2226EUR$2,500USD£1,929GBP
- Report
- November 2021
- 51 Pages
Global
€14928EUR$17,350USD£12,500GBP
- Report
- November 2021
- 527 Pages
United States
From €7120EUR$7,995USD£6,170GBP
- Report
- October 2021
Global
€4230EUR$4,750USD£3,666GBP
- Report
- June 2021
- 140 Pages
United States
From €1558EUR$1,750USD£1,351GBP
€2226EUR$2,500USD£1,929GBP
- Report
- June 2021
- 102 Pages
Global
€19591EUR$22,000USD£16,979GBP
- Report
- May 2021
- 97 Pages
Global
€19591EUR$22,000USD£16,979GBP
- Report
- May 2021
- 45 Pages
Global
€1174EUR$1,318USD£1,017GBP
- Report
- April 2021
- 120 Pages
Global
€19591EUR$22,000USD£16,979GBP
- Report
- April 2021
- 191 Pages
Global
€19591EUR$22,000USD£16,979GBP
- Report
- March 2021
- 150 Pages
South Africa
From €2226EUR$2,500USD£1,929GBP
- Report
- February 2021
- 32 Pages
Global
€1174EUR$1,318USD£1,017GBP
- Report
- January 2021
- 38 Pages
Global
€1174EUR$1,318USD£1,017GBP
- Report
- January 2021
China
From €1950EUR$2,190USD£1,690GBP
- Report
- December 2020
- 200 Pages
Global
€3963EUR$4,450USD£3,434GBP
- Report
- November 2020
- 81 Pages
Global
From €3290EUR$3,958USD£2,951GBP
- Report
- November 2020
- 49 Pages
Global
€1174EUR$1,318USD£1,017GBP
- Report
- October 2020
- 85 Pages
Global
€19591EUR$22,000USD£16,979GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more